The role of preserving therapy of invasive cancer of the urinary bladder


Cite item

Full Text

Abstract

Cystectomy in the treatment of invasive cancer of the urinary bladder is not the only therapeutic modality in this pathology. In selected patients an alternative exists - transurethral resection of the urinary bladder followed by adjuvant concurrent chemotherapy and radiotherapy. The preserving therapy can be recommended to patients over 60 years of age in the presence of a low-grade solitary tumor of a mobile wall of the urinary bladder respectable with preservation of the organ capacity.

References

  1. Аль-Шукри С. X., Комяков Б. К., Горелов А. П., Прохожев А. Ю. Радикальная цистэктомия при раке мочевого пузыря. В кн.: Актуальные вопросы лечения онкоурологических заболеваний: Материалы 2-й Всероссийской науч. конф. с участием стран СНГ 21-22 ноября, Обнинск, 1997. Обнинск; 1997. 8-9.
  2. Морозов А. В., Антонов М. П., Павленко К. А. Замещение мочевого пузыря сегментом кишечника (ортотопическая реконструкция мочевого пузыря. Урол. и нефрол. 2000; 3: 17-22.
  3. Gburek В., Lieber М., Btute M. Comparison of Studer ileal neobladder and ileal conduit urinary diversion with respect to perioperative outcome and late complications. J. Urol. (Baltimore) 1998; 160(3, pt 1): 721-723.
  4. Hautmann R. E., De Petriconi R., Gottfried H.-W. et al. The ileal neobladder: complications and functional results in 363 patients after 11 years of follow-up. J. Urol. (Baltimore) 1999; 161 (2): 422-428.
  5. Studer U. E., Danuser H., Merz V. W. et al. Experience in 100 patients with ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segment. J. Urol. (Baltimore) 1995; 154(1): 49-56.
  6. Sweeney P., Kursh E. D., Resnick M. I. Partial cystectomy for muscle-invasive transitional and squamous carcinoma of the bladder- is it safe? J. Urol. (Baltimore) 1992; 19: 1701-1711.
  7. Hall R. R. Bladder-preserving treatments. In: Vogelzang N. J. et al., eds. Genitourinary oncology. 2-nd ed. Philadelphia: Lippincott Williams and Wilkins; 1999. 483-486.
  8. Simon S. D., Srougi M. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder. Progr. Clin. Biol. Res. 1990; 353: 169-174.
  9. Herr H. W., Scher H. I. Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. Cancer Treat. Res. 1992; 59: 99-103.
  10. Sternberg C. N., Pansadoro V., Lauretti S. et al. Neo-adjuvant M-VAC (methotrexate, vinblastine, adriomycin and cisplatin) chemotherapy and bladder preservation in infiltrating transitional cell carcinoma of the bladder. Urol. Oncol. 1995; 1: 127- 133.
  11. Socquet Y. Combined surgery and adjuvant chemotherapy with high dose methotrexate and folinic acid resque (HDMTX-CF) for infiltrating tumors of the bladder. Br. J. Urol. 1981; 53:439- 443.
  12. Barnes R. W., Dick A. L., Hadley H. L. et al. Survival following transurethral resection of bladder carcinoma. Cancer Res. 1977; 37: 2895-2898.
  13. Herr H. W. Conservative management of muscle-infiltrating bladder cancer: prospective experience. J. Urol. (Baltimore) 1987; 138: 1162-1163.
  14. Henry K., Miller J., Mari M. et al. Comparison of transurethral resection to radical therapies for stage В bladder tumors. J. Urol. (Baltimore) 1988; 140: 964-967.
  15. Sternberg C. N., Pansadoro V., Calabro F. et al. Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder. Ann. Oncol. 1999; 10: 1301-1305.
  16. Shipley W. U., Prout G. R., Kaufman D. S. et al. Invasive bladder carcinoma, the impotence of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer (Philad.) 1987; 60: 514-520.
  17. Tester W., Porter A., Heaney J. et al. Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer. J. Clin. Oncol. 1996; 14: 119-126.
  18. Martinez-Pineiro J. A., Jimenez L. J., Martinez-Pineiro L. et al. Aggressive transurethral resection combined with systemic chemotherapy for locally invasive TCC of the urinary bladder. Proc. Soc. Int. Urol. 1999; 226: abstr. 216.
  19. Noguera-March J. L., Ojera A., Figueiredo L. et al. Radical TUR and M-VAC in the treatment of infiltrating bladder tumors. Proc. Soc. Int. Urol. 1999; 226: abstr. 215.
  20. Dunst J., Sauer R., Schrott К. М. et al. Organ-sparing treatment of advanced bladder cancer: 10-year experience. Int. J. Radiaf. Oncol. Biol. Phys. 1994; 30: 261-266.
  21. Kachnic L. A., Kaufman D. S., Griffin P. P. et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J. Clin. Oncol. 1997; 15: 1022-1029.
  22. Shipley W. U., Winter K. A., Lee R. et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of RTOG 8903. J. Clin. Oncol. 1998; 16: 3576-3583.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2005 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies